Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |